IL2 and T-cell non-Hodgkin lymphoma: The first description of HTLV-I came after the discovery of the human T-cell growth factor (interleukin-2; IL-2), allowing long-term in vitro culture of T cells and the establishment of T-cell lines from a patient with a cutaneous T-cell lymphoma [1–3].